Pharmaceutical manufacturer operating in the EU for 50+ years. Activities include scientific development, manufacturing, out-licensing, marketing, and distribution of high-quality generic medicines. The company owns several production facilities that all comply with EU GMP requirements. Key dosage forms include conventional solids, cytostatic injectables, and cytostatic orals. The company holds an in-house R&D and Intellectual property business unit, as well as a regulatory affairs team that prepares CTD dossiers and maintains direct contact with regulatory agencies worldwide. The portfolio includes more than three thousand MA sets approved in the EU while hundreds of MA are in progress. Key therapy lines are cardiovascular, CNS, diabetes, immunology, oncology, and more. The company is active in nearly 100 countries worldwide, selling its products in Africa, Asia, Australia, Europe, LATAM, and the Middle East.

Established in 2018, this manufacturer specializes in exporting and manufacturing pharmaceutical active pharmaceutical ingredients (APIs) and finished formulations, including tablets, capsules, pre-filled syringes, dry syrups, creams, ointments, injectables (liquids and powder), eye/ear drops, IV fluids, and surgical products. As a CTD dossier owner and manufacturer, it holds EU/WHO GMP certifications, ensuring compliance with international quality standards. The manufacturer operates advanced production lines adhering to stringent GMP guidelines. As a CTD dossier owner and manufacturer, its products are distributed across various regions, including Central America, non-EU Europe, the Middle East, Oceania, South America, and South Asia.

Established in 1992, this manufacturer employs approximately 892 individuals and specializes in pharmaceutical finished dosage forms, active pharmaceutical ingredients (APIs), and drug intermediates. As a CTD dossier owner and manufacturer, it holds GMP approvals from multiple countries, ensuring compliance with international quality standards. The manufacturer operates advanced production lines for metered dose inhalers, dry powder inhalers, nebulization solutions, and tablets, adhering to stringent GMP guidelines. As a CTD dossier owner and manufacturer, its products are distributed in over 25 countries worldwide. With a focus on innovation, the manufacturer is a CTD dossier owner and manufacturer, dedicated to developing high-quality pharmaceutical solutions.